3rd Quarter - Report
DENNY MILLER ASSOCIATES for CELL THERAPEUTICS
Client
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
European Union approval of US cancer drugs.
Foreign entity interest: Italian Embassy.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JUDSON GREIF | — |
| SANDRA MATHIESEN | — |
| WILL STONE | — |
Medical/Disease Research/Clinical Labs MED
S. 3187, Food and Drug Administration Safety and Innovation Act of 2012, provisions relating to the approval of new drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JUDSON GREIF | — |
| SANDRA MATHIESEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.